CMA clears NHS healthcare tech deal
iStock The Competition and Markets Authority (CMA) referred UnitedHealth’s £1.2bn purchase of EMIS for an in-depth Phase 2 investigation by an independent inquiry group in March 2023, after identifying competition concerns that warranted further investigation during an initial Phase 1 review. Following a thorough investigation, the CMA has today confirmed that the transaction does not